What Is Quality by Design and Why It Drives Israeli PharmaUntitledBuild Quality in from the Start
The Quality by Design Training in Israel is a one-day, instructor-led programme that teaches the Quality by Design (QbD) approach to pharmaceutical and biopharmaceutical development, where quality is engineered into the product from the design stage rather than tested in at the end. Grounded in the ICH Q8(R2), Q9, Q10 and Q11 guidelines and the expectations of regulators such as the FDA and EMA, the course shows you how to move from the Quality Target Product Profile (QTPP) through critical quality attributes, risk assessment, design of experiments and the design space to a robust control strategy. These are the tools that Teva, Taro, Dexcel, Kamada and Israel's wider generics, API and biologics base build into development and regulatory submissions. It suits formulation scientists, process development engineers, analytical scientists, QA professionals and CMC regulatory specialists who want practical, on-the-job capability. This is a skills programme, not a certification course, so you leave with capability you can apply immediately and a course completion record from Invensis Learning.










